HMBD-501-a novel Fc engineered, exatecan-based next generation HER3 targeting antibody drug conjugate shows robust efficacy and tolerability in pre-clinical solid tumor modelsSuhail Ahmed Kabeer Rasheed,Dipti Thakkar, Shalini Paliwal, Wen Jie Chin, Akshaya Bansal, Ben Ayers, Che Theng Ng, Brendon Hanson,Piers Ingram,Jerome Boyd-KirkupCANCER RESEARCH（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
